Parenting Programs for Substance Abuse-related Parent-Child Relationship Issues
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to compare the effectiveness of the Breaking the Cycle (BTC) and Maxxine Wright (MW) programs in substance-involved mothers and their children. One key difference between the two programs is that the BTC program contains an infant mental health component while the MW program primarily focuses on the mothers. The main questions the trial aims to answer are: * Do children at BTC demonstrate enhanced infant mental health compared to children at MW up to 2 years post-intervention? * Do mother-child dyads at BTC experience more decreases in child adverse childhood experiences (ACE), maternal stress, and mental health symptoms and have better home environment scores, parenting attitudes, and mother-child relationship scores compared to mother-child dyads at MW? * Are enhanced infant mental health outcomes associated with children's lower psychosocial risk scores and mothers with lower ACE scores, lower depression and anxiety scores, and lower maternal stress? * Are the associations between treatment dose and infant mental health scores mediated by parenting attitudes and the mother-child relationship? Does child exposure to psychosocial risk moderate the association between treatment dose and child outcomes? * How do the mechanisms of change lead to the effectiveness of BTC? What are the potential lifetime health and non-health outcomes of at-risk children at BTC? What is the long-term social return on investment (SROI) of BTC? Participants will complete several questionnaires at three timepoints while receiving services at either BTC or MW: during the intake phase, 12 months after their engagement in services and 24 months after their engagement in services. Given that the two programs serve a similar demographic of women, researchers will compare the BTC group and the MW group to establish the comparative effectiveness and mechanisms of change of the infant mental health component of BTC.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Breaking the Cycle Program treatment for substance abuse-related parent-child relationship issues?
Research shows that programs addressing both substance abuse and parenting can reduce substance use and improve parenting skills. Similar programs, like the Nurturing Program for Families in Substance Abuse Treatment, have been effective in enhancing parenting satisfaction and competence, which suggests that the Breaking the Cycle Program may also be beneficial.12345
Is the Parenting Programs for Substance Abuse-related Parent-Child Relationship Issues treatment safe for participants?
How is the Breaking the Cycle Program treatment different from other treatments for substance abuse-related parent-child relationship issues?
Eligibility Criteria
This trial is for English-speaking mothers with a child under 6 years old, who are receiving services at either the Breaking the Cycle (BTC) or Maxxine Wright (MW) programs due to substance involvement.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intake
Participants complete initial assessments and questionnaires as part of the intake process
Intervention
Participants receive services from either the Breaking the Cycle (BTC) or Maxxine Wright (MW) programs
Follow-up
Participants are monitored for changes in child development and maternal mental health outcomes
Treatment Details
Interventions
- Breaking the Cycle Program
- Maxxine Wright Program
Breaking the Cycle Program is already approved in Canada for the following indications:
- Substance abuse intervention for mothers and children
- Infant mental health support
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Ottawa
Lead Sponsor